Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients

Clinical trial NCT06561620 · RECRUITING

Trial details

NCT number: NCT06561620
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

3-year Disease-free Survival

Start date: 2024-05-01
Primary completion: 2027-05-01
Enrollment: 592

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.